Discovery of Novel Drug Candidates for Alzheimer’s Disease by Molecular Network Modeling
To identify the molecular mechanisms and novel therapeutic agents of late-onset Alzheimer’s disease (AD), we performed integrative network analysis using multiple transcriptomic profiles of human brains. With the hypothesis that AD pathology involves the whole cerebrum, we first identified co-expres...
Main Authors: | Li, Q. (Author), Lu, Y. (Author), Wang, Z. (Author), Wu, W. (Author), Zhang, X. (Author), Zhao, H. (Author), Zhou, J. (Author), Zuo, Z. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
by: Ali Khosravi, et al.
Published: (2019-06-01) -
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
by: Andrea Gelemanović, et al.
Published: (2021-01-01) -
AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery
by: Yadi Zhou, et al.
Published: (2021-01-01) -
Predicting the Potency of Anti-Alzheimer’s Drug Combinations Using Machine Learning
by: Thomas J Anastasio
Published: (2021-01-01) -
Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy
by: Odeya Damri, et al.
Published: (2021-12-01)